- Home
- IDYA vs JPC Comparison
IDYA vs JPC Comparison
Compare IDYA & JPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- JPC
- Stock Information
- Founded
- IDYA 2015
- JPC 2003
- Country
- IDYA United States
- JPC United States
- Employees
- IDYA N/A
- JPC N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- JPC Investment Managers
- Sector
- IDYA Health Care
- JPC Finance
- Exchange
- IDYA Nasdaq
- JPC Nasdaq
- Market Cap
- IDYA 2.6B
- JPC 2.6B
- IPO Year
- IDYA 2019
- JPC N/A
- Fundamental
- Price
- IDYA $26.64
- JPC $8.06
- Analyst Decision
- IDYA Strong Buy
- JPC
- Analyst Count
- IDYA 12
- JPC 0
- Target Price
- IDYA $53.08
- JPC N/A
- AVG Volume (30 Days)
- IDYA 750.9K
- JPC 998.5K
- Earning Date
- IDYA 11-04-2024
- JPC 01-01-0001
- Dividend Yield
- IDYA N/A
- JPC 7.57%
- EPS Growth
- IDYA N/A
- JPC N/A
- EPS
- IDYA N/A
- JPC N/A
- Revenue
- IDYA $3,922,000.00
- JPC N/A
- Revenue This Year
- IDYA N/A
- JPC N/A
- Revenue Next Year
- IDYA $158.10
- JPC N/A
- P/E Ratio
- IDYA N/A
- JPC N/A
- Revenue Growth
- IDYA N/A
- JPC N/A
- 52 Week Low
- IDYA $26.41
- JPC $5.94
- 52 Week High
- IDYA $47.74
- JPC $7.36
- Technical
- Relative Strength Index (RSI)
- IDYA 33.96
- JPC 45.71
- Support Level
- IDYA $27.52
- JPC $8.03
- Resistance Level
- IDYA $32.67
- JPC $8.12
- Average True Range (ATR)
- IDYA 1.44
- JPC 0.07
- MACD
- IDYA -0.04
- JPC -0.00
- Stochastic Oscillator
- IDYA 3.75
- JPC 30.00
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.
About JPC Nuveen Preferred & Income Opportunities Fund
Nuveen Preferred & Income Opportunities Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. It invests its managed assets in preferred securities, and in other types of securities, primarily income-oriented securities such as corporate and taxable municipal debt and common equity.